喘,COPD和喘-COPD重叠综合征患者的住院结果
Mrinalini Modak1, Wiktoria M Rowlands1, Joelle Sleiman2
1Department of Medicine, University of Oklahoma, Health Sciences Center, Oklahoma City, Oklahoma, United States.
Chronic obstructive pulmonary diseases (Miami, Fla.)
|June 24, 2025
概括
喘-COPD重叠 (ACO) 患者患有更多的并发症和更长的住院时间,但死亡率不高于仅患有喘或COPD的患者. ACO再录取率与喘相似,但低于COPD.
科学领域:
- 肺部医学 肺部医学
- 医疗保健服务研究 医疗服务研究
- 临床流行病学临床流行病学
背景情况:
- 喘和慢性阻塞性肺病 (COPD) 在美国代表着严重的医疗负担.
- 喘-COPD重叠 (ACO) 现型与恶化和医疗保健利用率的增加有关.
- 对ACO的医院结局尚未得到充分记录.
研究的目的:
- 调查和比较喘,COPD和ACO患者的医院治疗结果.
- 分析这些呼吸道疾病之间的死亡率,停留时间和再入院率的差异.
主要方法:
- 从2012年至2015年利用了医疗保健成本和利用项目全国再接收数据库 (HCUP-NRD).
- 使用ICD-9-CM代码将患者分类为喘,COPD或ACO.
- 使用加权回归分析来评估住院结果和国家估计.
主要成果:
- ACO患者比COPD患者年轻,呼吸衰竭率更高,住院时间更长.
- 与ACO相比,COPD和喘的入院死亡率较高.
- 所有原因的再入院率高于COPD (15.7%) 和类似的ACO (11.5%) 和喘 (10.7%).
结论:
- ACO与伴随性疾病增加,住院时间延长和初次入院期间的成本增加有关.
- 尽管有这些因素,但ACO并没有显示出较高的住院死亡率或并发症率,而不是单独的喘或COPD.
- 这些发现强调了ACO疾病负担的复杂性及其独特的医院结局概况.
更多相关视频
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
329
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
329
01:24Asthma-III: Symptoms and Complications
2.7K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.7K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K